May 20, 2024 11:37 AM EDTUpdated 03:39 PM
People
FDA+

Up­dat­ed: Lob­by­ing group BIO re­struc­tures staff in shake­up un­der new CEO

Drew Armstrong

Executive Editor

The trade group BIO has part­ed ways with 30 em­ploy­ees, in­clud­ing sev­er­al se­nior lead­ers, in what sources are de­scrib­ing as a re­struc­tur­ing of the trade …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times